Table of Contents Table of Contents
Previous Page  91 / 412 Next Page
Information
Show Menu
Previous Page 91 / 412 Next Page
Page Background

Traditionally, patients warranting direct microlar-

yngoscopy after office biopsy are those with limited tis-

sue obtained during attempted office biopsy, a concern

regarding false-negative office biopsy results, a require-

ment for disease volume reduction to avoid respiratory

or swallowing impairment, and a need for excision of the

lesion to improve the voice. Other advantages of direct

microlaryngoscopy include a more detailed examination

of the extent of a tumor, more accurate biopsy capabil-

ities, and the option for definitive treatment by excision

for many lesions.

Despite the popularity of office biopsy, there is a

paucity of data in the literature evaluating the accuracy

compared to histologic diagnosis at operation. The goals

of this study are to determine the accuracy of office biop-

sies when compared to direct microlaryngoscopy and to

evaluate its role and diagnostic value.

MATERIALS AND METHODS

A retrospective medical chart review was performed from

January 1, 2010, to July 31, 2013, after receiving approval from

the Institutional Review Board Human Subjects Committee.

This review identified 261 patients in the clinical practices of

the authors who underwent office biopsy (current procedural

terminology code 31576) for laryngeal and pharyngeal lesions.

Patients’ records were then reviewed to determine those who

underwent direct microlaryngoscopy with biopsy.

Patients who had resolution of the lesion following biopsy,

surveillance of a previously histologically proven benign diagno-

sis, and a definitive diagnosis of cancer who proceeded to non-

surgical definitive treatment were excluded from the study. We

also excluded current anticoagulation, anterior commissure

lesions, submucosal lesions, and anatomically obstructive

pathology. Patients with brush biopsy alone were also excluded.

The pathology reports were reviewed for consistency between

office and surgical specimens and compared to clinical diagno-

ses. The flow of the patients is summarized in Figure 1.

Office biopsies were performed using distal chip video endo-

scopes (ENT-5000, Vision Sciences, Inc. or VNL-1570STK,

KayPENTAX Montvale, NJ) in conjunction with a 2-mm channel

endosheath and 1.8-mm nonserrated cup biopsy forceps. The

nasal cavity was anesthetized with aerosolized 4% lidocaine with

epinephrine 1:100,000 or 4% lidocaine with phenylephrine hydro-

chloride. The channel-sheathed video endoscope was then passed

transnasally into the laryngopharynx. Topical laryngopharyngeal

anesthesia was achieved by delivering 0.5 cc of plain 4% lido-

caine to the laryngeal surface of the epiglottis. Once supraglottic

anesthesia was achieved, 1 to 2 cc of plain 4% lidocaine was then

delivered topically to the glottis. The 1.8-mm biopsy forcep was

then passed under videoendoscopic guidance and biopsies were

performed.

Direct microlaryngoscopy with biopsy was performed under

general anesthesia, and lesions were visualized with a zero-

degree telescope and binocular microscope. Lesions were excised

or sampled for pathologic evaluation using phonosurgical instru-

ments. The procedures included a submucosal dissection in order

to obtain epithelial basement membrane in the specimen.

Office biopsy results were divided into clinically relevant

groups that would normally used to direct patient care algo-

rithms. For example, mild to moderate dysplasia was separated

from severe dysplasia and carcinoma in situ (CIS)/squamous

cell carcinoma (SCC). For statistical analysis, we considered

three groups: 1) malignant and premalignant (SCC, CIS, and

severe dysplasia); 2) lesions of uncertain significance (mild–

moderate dysplasia and hyperkeratosis); and 3) benign lesions.

Patients who were noted to have a dual diagnosis on histology

(e.g., inflammation with mild dysplasia) were analyzed within

the group that would direct their final treatment.

To test interrater reliability, we utilized Kendall’s coeffi-

cient of concordance for the numerically coded ordinal responses

Fig. 1. Flow of office biopsy patients. (Operating room biopsy diagnoses are listed in the last row). [Color figure can be viewed in the online

issue, which is available at

wileyonlinelibrary.com.

]

Laryngoscope 125: April 2015

Richards et al.: Office-Based Biopsy for Laryngopharyngeal Lesions

71